Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Detection of individual T-cell reaction patterns against tumor-associated antigens (TAA) in tumor patients as a basis for the individual therapeutic vaccination of patients

Detection of individual T-cell reaction patterns against tumor-associated antigens (TAA) in tumor patients as a basis for the individual therapeutic vaccination of patients

US Patent 8349558 · Granted Jan 8, 2013

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

MHC-independent tumor-associated antigens2021
MHC-independent tumor-associated antigens2021
T cell receptors with MHC independent binding to GM-CSF receptor alpha chain2018
T cell receptors with MHC independent binding to GM-CSF receptor alpha chain2018
Method for modulating activity of T lymphocytes2015
Isolated tumor rejection antigen precursor proteins MAGE-2 and MAGE-32011
Isolated peptide which binds to HLA-Cw*07 and uses thereof2009
MAGE peptides presented by HLA class II molecules2008
Tumor antigens and CTL clones isolated by a novel procedure2008
Nucleic acid molecules encoding the MAGE-1 tumor rejection antigen precursor2008
MAGE-A4 antigenic peptides and uses thereof2007
MAGE-3 peptides presented by HLA class II molecules2007